125 related articles for article (PubMed ID: 12067545)
21. Investigation of the covalent modification of the catalytic triad of human cytomegalovirus protease by pseudo-reversible beta-lactam inhibitors and a peptide chloromethylketone.
Haley TM; Angier SJ; Borthwick AD; Montgomery DS; Purvis IJ; Smart DH; Bessant C; Van Wely C; Hart GJ
J Mass Spectrom; 1998 Dec; 33(12):1246-55. PubMed ID: 9875526
[TBL] [Abstract][Full Text] [Related]
22. Design and synthesis of monocyclic beta-lactams as mechanism-based inhibitors of human cytomegalovirus protease.
Borthwick AD; Weingarten G; Haley TM; Tomaszewski M; Wang W; Hu Z; Bedard J; Jin H; Yuen L; Mansour TS
Bioorg Med Chem Lett; 1998 Feb; 8(4):365-70. PubMed ID: 9871686
[TBL] [Abstract][Full Text] [Related]
23. The Journey to the Discovery of Boceprevir: an NS3-NS4 HCV protease inhibitor for the treatment of chronic hepatitis C.
Chen KX; Njoroge FG
Prog Med Chem; 2010; 49():1-36. PubMed ID: 20855037
[No Abstract] [Full Text] [Related]
24. 2(S)-(Cycloalk-1-enecarbonyl)-1-(4-phenyl-butanoyl)pyrrolidines and 2(S)-(aroyl)-1-(4-phenylbutanoyl)pyrrolidines as prolyl oligopeptidase inhibitors.
Jarho EM; Venäläinen JI; Poutiainen S; Leskinen H; Vepsäläinen J; Christiaans JA; Forsberg MM; Männistö PT; Wallén EA
Bioorg Med Chem; 2007 Mar; 15(5):2024-31. PubMed ID: 17215128
[TBL] [Abstract][Full Text] [Related]
25. Potent beta-lactam inhibitors of human cytomegalovirus protease.
Yoakim C; Ogilvie WW; Cameron DR; Chabot C; Grand-Maître C; Guse I; Haché B; Kawai S; Naud J; O'Meara JA; Plante R; Déziel R
Antivir Chem Chemother; 1998 Sep; 9(5):379-87. PubMed ID: 9875391
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of triazole-Tethered pyrrolidine libraries: novel ECE inhibitors.
Kitas EA; Löffler BM; Daetwyler S; Dehmlow H; Aebi JD
Bioorg Med Chem Lett; 2002 Jul; 12(13):1727-30. PubMed ID: 12067547
[TBL] [Abstract][Full Text] [Related]
27. Selective nonpeptidic inhibitors of herpes simplex virus type 1 and human cytomegalovirus proteases.
Matsumoto M; Misawa S; Chiba N; Takaku H; Hayashi H
Biol Pharm Bull; 2001 Mar; 24(3):236-41. PubMed ID: 11256477
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and anti-HCMV activity of 1-acyl-beta-lactams and 1-acylazetidines derived from phenylalanine.
Gerona-Navarro G; Pérez de Vega MJ; García-López MT; Andrei G; Snoeck R; Balzarini J; De Clercq E; González-Muñiz R
Bioorg Med Chem Lett; 2004 May; 14(9):2253-6. PubMed ID: 15081019
[TBL] [Abstract][Full Text] [Related]
29. Peptidomimetic inhibitors of the human cytomegalovirus protease.
Ogilvie W; Bailey M; Poupart MA; Abraham A; Bhavsar A; Bonneau P; Bordeleau J; Bousquet Y; Chabot C; Duceppe JS; Fazal G; Goulet S; Grand-Maître C; Guse I; Halmos T; Lavallée P; Leach M; Malenfant E; O'Meara J; Plante R; Plouffe C; Poirier M; Soucy F; Yoakim C; Déziel R
J Med Chem; 1997 Dec; 40(25):4113-35. PubMed ID: 9406601
[TBL] [Abstract][Full Text] [Related]
30. beta-Lactam derivatives as inhibitors of human cytomegalovirus protease.
Yoakim C; Ogilvie WW; Cameron DR; Chabot C; Guse I; Haché B; Naud J; O'Meara JA; Plante R; Déziel R
J Med Chem; 1998 Jul; 41(15):2882-91. PubMed ID: 9667976
[TBL] [Abstract][Full Text] [Related]
31. Novel yeast cell-based assay to screen for inhibitors of human cytomegalovirus protease in a high-throughput format.
Cottier V; Barberis A; Lüthi U
Antimicrob Agents Chemother; 2006 Feb; 50(2):565-71. PubMed ID: 16436711
[TBL] [Abstract][Full Text] [Related]
32. The design and development of 2-aryl-2-hydroxy ethylamine substituted 1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamides as inhibitors of human cytomegalovirus polymerase.
Tanis SP; Strohbach JW; Parker TT; Moon MW; Thaisrivongs S; Perrault WR; Hopkins TA; Knechtel ML; Oien NL; Wieber JL; Stephanski KJ; Wathen MW
Bioorg Med Chem Lett; 2010 Mar; 20(6):1994-2000. PubMed ID: 20167488
[TBL] [Abstract][Full Text] [Related]
33. trans-(3S,4S)-Disubstituted pyrrolidines as inhibitors of the human aspartyl protease renin. Part I: prime site exploration using an amino linker.
Lorthiois E; Cumin F; Ehrhardt C; Kosaka T; Sellner H; Ostermann N; Francotte E; Wagner T; Maibaum J
Bioorg Med Chem Lett; 2015 Apr; 25(8):1782-1786. PubMed ID: 25782742
[TBL] [Abstract][Full Text] [Related]
34. Structure-activity relationships of 4-hydroxy-4-biaryl-proline acylsulfonamide tripeptides: A series of potent NS3 protease inhibitors for the treatment of hepatitis C virus.
Wang AX; Chen J; Zhao Q; Sun LQ; Friborg J; Yu F; Hernandez D; Good AC; Klei HE; Rajamani R; Mosure K; Knipe JO; Li D; Zhu J; Levesque PC; McPhee F; Meanwell NA; Scola PM
Bioorg Med Chem Lett; 2017 Feb; 27(3):590-596. PubMed ID: 28011221
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C virus resistance to protease inhibitors.
Halfon P; Locarnini S
J Hepatol; 2011 Jul; 55(1):192-206. PubMed ID: 21284949
[TBL] [Abstract][Full Text] [Related]
36. Potent pyrrolidine- and piperidine-based BACE-1 inhibitors.
Iserloh U; Wu Y; Cumming JN; Pan J; Wang LY; Stamford AW; Kennedy ME; Kuvelkar R; Chen X; Parker EM; Strickland C; Voigt J
Bioorg Med Chem Lett; 2008 Jan; 18(1):414-7. PubMed ID: 18023580
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and structure-activity relationships of potent 4-fluoro-2-cyanopyrrolidine dipeptidyl peptidase IV inhibitors.
Fukushima H; Hiratate A; Takahashi M; Mikami A; Saito-Hori M; Munetomo E; Kitano K; Chonan S; Saito H; Suzuki A; Takaoka Y; Yamamoto K
Bioorg Med Chem; 2008 Apr; 16(7):4093-106. PubMed ID: 18243000
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
Cheng XC; Wang Q; Fang H; Tang W; Xu WF
Bioorg Med Chem; 2008 Sep; 16(17):7932-8. PubMed ID: 18718763
[TBL] [Abstract][Full Text] [Related]
39. Accounting for strain variations and resistance mutations in the characterization of hepatitis C NS3 protease inhibitors.
Ehrenberg AE; Schmuck B; Anwar MI; Gustafsson SS; Stenberg G; Danielson UH
J Enzyme Inhib Med Chem; 2014 Dec; 29(6):868-76. PubMed ID: 24517372
[TBL] [Abstract][Full Text] [Related]
40. Pyrrolidine-carboxamides and oxadiazoles as potent hNK1 antagonists.
Young JR; Eid R; Turner C; DeVita RJ; Kurtz MM; Tsao KL; Chicchi GG; Wheeldon A; Carlson E; Mills SG
Bioorg Med Chem Lett; 2007 Oct; 17(19):5310-5. PubMed ID: 17723300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
